Azzour D. Hazzan

4.4k total citations
17 papers, 207 citations indexed

About

Azzour D. Hazzan is a scholar working on Nephrology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Azzour D. Hazzan has authored 17 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Azzour D. Hazzan's work include Dialysis and Renal Disease Management (7 papers), Iron Metabolism and Disorders (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Azzour D. Hazzan is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Iron Metabolism and Disorders (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Azzour D. Hazzan collaborates with scholars based in United States. Azzour D. Hazzan's co-authors include Steven Fishbane, Candice Halinski, Anna Mathew, Kenar D. Jhaveri, Hitesh H. Shah, Steven Fishbane, Eduardo Lacson, Rimda Wanchoo, Lin Ma and Myriam Kline and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Azzour D. Hazzan

16 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azzour D. Hazzan United States 8 109 31 28 25 23 17 207
Hyemin Jeong South Korea 11 37 0.3× 26 0.8× 26 0.9× 11 0.4× 8 0.3× 31 271
E Jacobs Netherlands 8 18 0.2× 34 1.1× 51 1.8× 47 1.9× 5 0.2× 14 296
Liou Cao China 11 249 2.3× 11 0.4× 32 1.1× 3 0.1× 9 0.4× 35 374
M.D. Gardner United Kingdom 9 72 0.7× 144 4.6× 18 0.6× 6 0.2× 26 1.1× 20 422
Andrese Aline Gasparin Brazil 12 49 0.4× 5 0.2× 33 1.2× 11 0.4× 2 0.1× 31 324
Margriet Huisman Netherlands 8 40 0.4× 12 0.4× 56 2.0× 3 0.1× 3 0.1× 8 283
Deni Aldo Procaccini Italy 8 68 0.6× 2 0.1× 22 0.8× 18 0.7× 7 0.3× 18 325
Wataru Akita Japan 9 322 3.0× 144 4.6× 48 1.7× 3 0.1× 50 2.2× 16 422
Daniel Eriksson Germany 13 67 0.6× 15 0.5× 72 2.6× 1 0.0× 15 0.7× 38 539
Philip A. Kalra United Kingdom 9 372 3.4× 19 0.6× 43 1.5× 1 0.0× 21 0.9× 15 490

Countries citing papers authored by Azzour D. Hazzan

Since Specialization
Citations

This map shows the geographic impact of Azzour D. Hazzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azzour D. Hazzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azzour D. Hazzan more than expected).

Fields of papers citing papers by Azzour D. Hazzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azzour D. Hazzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azzour D. Hazzan. The network helps show where Azzour D. Hazzan may publish in the future.

Co-authorship network of co-authors of Azzour D. Hazzan

This figure shows the co-authorship network connecting the top 25 collaborators of Azzour D. Hazzan. A scholar is included among the top collaborators of Azzour D. Hazzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azzour D. Hazzan. Azzour D. Hazzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Barnett, Richard, Kenar D. Jhaveri, Bessy Suyin Flores Chang, et al.. (2020). Slow Low-Efficiency Dialysis (SLED) Implementation During the COVID-19 Pandemic Surge. Journal of the American Society of Nephrology. 31(10S). 805–805. 1 indexed citations
2.
John, Veena S., Nagashree Seetharamu, & Azzour D. Hazzan. (2020). Renal insufficiency in patients on PARP inhibitors: Case-based review of possible mechanisms and management. 5(1). 8–12.
3.
Hazzan, Azzour D., et al.. (2017). Medication discrepancies in late-stage chronic kidney disease. Clinical Kidney Journal. 11(4). 507–512. 11 indexed citations
4.
Shah, Hitesh H., Azzour D. Hazzan, & Steven Fishbane. (2016). Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis. Seminars in Nephrology. 36(2). 124–129. 12 indexed citations
5.
Wanchoo, Rimda, Azzour D. Hazzan, & Steven Fishbane. (2016). Update on the End‐Stage Renal Disease Quality Incentive Program. Seminars in Dialysis. 29(2). 144–147. 4 indexed citations
6.
Hazzan, Azzour D., et al.. (2016). Epidemiology and Challenges to the Management of Advanced CKD. Advances in Chronic Kidney Disease. 23(4). 217–221. 14 indexed citations
7.
Fishbane, Steven, Azzour D. Hazzan, Kenar D. Jhaveri, Lin Ma, & Eduardo Lacson. (2016). Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis. Clinical Journal of the American Society of Nephrology. 11(6). 1063–1072. 26 indexed citations
8.
Shah, Hitesh H., Azzour D. Hazzan, & Steven Fishbane. (2015). Novel iron-based phosphate binders in patients with chronic kidney disease. Current Opinion in Nephrology & Hypertension. 24(4). 1–1. 7 indexed citations
9.
Jhaveri, Kenar D., et al.. (2014). Intravenous albumin infusion is an effective therapy for hyponatremia in patient with malignant ascites. Indian Journal of Nephrology. 24(1). 51–51. 6 indexed citations
10.
Mathew, Anna, Azzour D. Hazzan, Kenar D. Jhaveri, et al.. (2014). Increasing Hip Fractures in Patients Receiving Hemodialysis and Peritoneal Dialysis. American Journal of Nephrology. 40(5). 451–457. 30 indexed citations
11.
Fishbane, Steven, Azzour D. Hazzan, Candice Halinski, & Anna Mathew. (2014). Challenges and opportunities in late-stage chronic kidney disease. Clinical Kidney Journal. 8(1). 54–60. 35 indexed citations
12.
Fishbane, Steven & Azzour D. Hazzan. (2014). FIND-CKD: intravenous iron in predialysis CKD. Nature Reviews Nephrology. 10(9). 488–489. 1 indexed citations
13.
Hazzan, Azzour D., Hitesh H. Shah, Susana Hong, et al.. (2014). Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer. Kidney International. 86(1). 34–39. 21 indexed citations
14.
Halinski, Candice, et al.. (2014). Improving outcomes in late-stage kidney disease: the healthy transitions program.. PubMed. 28(10). 18–20, 22. 3 indexed citations
15.
Shirazian, Shayan, Myriam Kline, Dennis G. Moledina, et al.. (2013). Longitudinal Predictors of Uremic Pruritus. Journal of Renal Nutrition. 23(6). 428–431. 29 indexed citations
16.
Gitman, Michael, et al.. (2012). Ranolazine, Tacrolimus, and Diltiazem Might be a Hazardous Combination in a Transplant Patient. Renal Failure. 34(2). 251–253. 2 indexed citations
17.
Fishbane, Steven & Azzour D. Hazzan. (2012). Meeting the 2012 QIP (Quality Incentive Program) Clinical Measures: Strategies for Dialysis Centers. American Journal of Kidney Diseases. 60(5). S5–S13. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026